{"name":"RSV Therapeutics LLC","slug":"rsv-therapeutics-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"XC221","genericName":"XC221","slug":"xc221","indication":"Treatment of COVID-19","status":"phase_3"}]}],"pipeline":[{"name":"XC221","genericName":"XC221","slug":"xc221","phase":"phase_3","mechanism":"XC221 is a small molecule that inhibits the activity of the SARS-CoV-2 main protease.","indications":["Treatment of COVID-19"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxNRzVyM3JucU4xX1ZtTHVsWFY2dm5iOGY1VlFkWkt4c25zUTVQMVpwQ3ZieExqOG95OE5kRlNsZHFKV0lpNmdON05HdlZvYTZZMHlzVlVnbG5JY0tYbGM5NFJ2QzNxQlRZOGQ2bUVuemZxZ3l5NGgtMGpoWXp6SmRlbFJBZm10c29reV9jME9vdEJaX041RXp6VjJQUnRrcXF1cTJ6Mkh4STFUVnhpc0poeFBhZThrNlFSaGkwWkY1aENVSDY4R3c4eGJPbld4QkdJRGYwSGNnQUxsSW1OWVJv?oc=5","date":"2026-02-02","type":"pipeline","source":"reuters.com","summary":"UK industry body says Sanofi in breach over RSV therapy claims against Pfizer - reuters.com","headline":"UK industry body says Sanofi in breach over RSV therapy claims against Pfizer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOWnlRYTh2d1NiZVhyS252VlQ2VGttbUZyYjFLRWlwdVJQSUcycjZoZVljZGpib0dUaHV1eEYyX1ZtOUdMeDRNN1lpckY3dHFYTzZHVkhaX19VeHJmcWRETXJJTzg2YkV3OG5LMUZvMF9rdEUwWXU3dUFoRXZxZWF6czNnRjg?oc=5","date":"2025-12-10","type":"regulatory","source":"statnews.com","summary":"FDA scrutiny of infant RSV shots escalates amid turmoil - statnews.com","headline":"FDA scrutiny of infant RSV shots escalates amid turmoil","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNMzdtTG9YQl9ydVZ6eTVpZDFZOENOUUoyT2o1QW04dklFd28xVHBQQktkNkNwZWpMQ1lXeThpZEI0RTVDREdXQkotajV2NnZnLVRISEVHVHVIcVY1MkhMUEpmWXY3b19hSXc1WENLbUwwVXA5ekNlVHdRdHRubjFiT2pJdmI4aC1PM2dzYXN0ekZZYkd2dGQ3VG9RS1Y0U2o0S1lyQkJpWDVlUU9rbHJCOHBjMm1janBfcnc?oc=5","date":"2025-11-20","type":"pipeline","source":"Fierce Pharma","summary":"Moderna takes out $1.5B loan, outlines commercial and R&D strategy in bid to break even by 2028 - Fierce Pharma","headline":"Moderna takes out $1.5B loan, outlines commercial and R&D strategy in bid to break even by 2028","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxPOXZZMkgyN3ltZGdKMnptMVAzSmxfNmNNSlVrVENLdEZSN2UwV3ZUaWtxcVNBOTVQSV9FREZxYVhZYzBlTnJxN2VHX1J6aXpfVTRrWWZoOEJCaDl1cGlWcXJ4LTZHTklTdndMS2lHQ1ZYSTNxMjBOWEJBa3VnWUhpa2VHb0paWm80YWVwOWxFNnRCcGFUV1plWWRDZ2d2eHplTVpTVldLOUdua0xUbVFsRFZwamFaR19MeEx6V1NsUHFMdnI5V0JPSWRacHR5TzNYd3dkLUs5VUJaQ2FPbV9oZmQ1SQ?oc=5","date":"2025-10-27","type":"regulatory","source":"respiratory-therapy.com","summary":"EU Panel Recommends Approval of Enflonsia for RSV Prevention - respiratory-therapy.com","headline":"EU Panel Recommends Approval of Enflonsia for RSV Prevention - respiratory","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNdl9nY2FiTUFnVmt4M28ya2txTVVtd3MwTkE0WWNaOGlMSE9nQUdDb2lqWlpWTkREb1NRQ1FVU0QtZlNtR1EwLUF6M0FBWXlkTkNrS01ubElnT2VWRlpwSFgyQ1JtYnFPRllRcXh4WENNdnUzbXZVajg4MFlIN21uZzNTR0s4dEltT1VHNG5rWGtVX0NqMFNwaUFKc3daOWpEdVNVMlNsUnBodWhZY1BIdU9XTDg?oc=5","date":"2025-09-29","type":"trial","source":"Fierce Biotech","summary":"Enanta sees RSV drug fail phase 2b's primary endpoint but finds positives in secondaries and subgroup - Fierce Biotech","headline":"Enanta sees RSV drug fail phase 2b's primary endpoint but finds positives in secondaries and subgroup","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQcHd3TDJtYzkzUEdLSlNpbFUwdllYcERnaWU5a3JXdVUzU1ZQWlp5aU5WUW0zVE5WeHVpWGlPSV9iSjBHaTlHZlUzdmcyTUJObzRUYW9ic19scXY4emFqZ3FNOXgzN0ZpRDk1ZF9YVVBMUWJURnFhRzRkZGpCVUdXUEJ4YkR6cm0yQjRNbmo0VmVpZW1LMlVwVW82QzVXUkg2dXgtWFI1RGxFcHVRY2JMWUlDeDk3SXc0cGhGVjFn?oc=5","date":"2025-06-25","type":"pipeline","source":"reuters.com","summary":"US CDC vaccine panel postpones vote on RSV therapies - reuters.com","headline":"US CDC vaccine panel postpones vote on RSV therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxNNFo4TFFRU2pEVG9pZV9TN19kQ2M5eHZnSnRMcGNwRGJmR2l2aTZTNmlLM2puZTBkS29EcjFzbFI1WnljaWMzTEx3aHlJQzdXQzg3MG5wWHJGcldXNDd6RWxCdFVHVk9HN2JXSTcwR2xxX0g4T2ZnUkdXSnlncnVkbGxuSFdHMTVzZDlNM0U5TDlUaDRHMnB0bDBIQzBRWmR0UkZWNGJYcWswZjdKb0VhX0tQYVNoQUUxejNzRmZVM2ZKWngtSmNSem5ZTUFlRVZBZnhv?oc=5","date":"2024-09-16","type":"regulatory","source":"reuters.com","summary":"Sanofi, AstraZeneca win US approval for RSV therapy manufacturing line - reuters.com","headline":"Sanofi, AstraZeneca win US approval for RSV therapy manufacturing line","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBlVzk0NFBuUm9QYS14TFhaS0ZYb0Znc053RDJzenVDYnE0MDgwMkFKZVpTMXhpN0J5cVFEM0NZQXdQLVRmT0NQWEw4NXRTVWxTWXg5TWZLOVpZNk5hV2Fr?oc=5","date":"2024-06-10","type":"pipeline","source":"nature.com","summary":"Farnesyltransferase inhibitor lonafarnib suppresses respiratory syncytial virus infection by blocking conformational change of fusion glycoprotein - nature.com","headline":"Farnesyltransferase inhibitor lonafarnib suppresses respiratory syncytial virus infection by blocking conformational cha","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNcVhkNG1Ca2RSZXAwT1pvQThKUmI0ZmNfUENWN1NSWjJ5bEowelVXSGlrZ2hVM1JWYmJralZBM1JEWllqSE96N29uNHlvOWZPbldFcm13NTdPa3RfMTd1dW9wZ1A1WkRtWWp5MGZZYlZYRmg0cThocmh1MlhMOW9ENUdfVFhUU2Z5dmVEUXhGSHl5VzFGLXFTQWkyN0p4TGJTSmY4WUs2NXVqUk5WNjVSOUJFWFVHVVdKNERBVUJQd09mQQ?oc=5","date":"2024-01-04","type":"regulatory","source":"respiratory-therapy.com","summary":"Canada Approves Pfizer’s RSV Vaccine - respiratory-therapy.com","headline":"Canada Approves Pfizer’s RSV Vaccine - respiratory","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPbXZvdzczaEVmVTZCSElhcWxuMDR1UVRVWEF3b0MxeWZJX3BXMFM1Vk1oOU04aFJ3NzZDRlpxUnRzM002dFZmbXhITkZsVkIzUHloRmVoSXJuS1NhaERvY0x0RGdSc3ZBR2pzcGlRWDE4QjE0YXRxRHRXXzVxS0NYVE84dzBKTTN3ckNyVVRaWFNCMGZvUm1tOXByQUVfaUZ0YzFMdUZjbVM2YVpqaVplWDdVZW1ob29IN1NmYWdRTQ?oc=5","date":"2023-12-25","type":"trial","source":"respiratory-therapy.com","summary":"Clinical Trial for RSV Vaccine Underway - respiratory-therapy.com","headline":"Clinical Trial for RSV Vaccine Underway - respiratory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPdUFCUWpNaVJERG85UnEwR2J2dlFRTzB2WGd4UENTdDA1WXZ1d2k1T24xXzNPQWU0YzMybjR3SExvZUZ3ODhIcDE4VmxqQnFYY0JHRl9qYjktN3M2Qzg2U01nb0lhU3Q5UkpkWGQ5MTU4aXZ0ZDFwaXBEd3hMU05paHQ5RUJrc3RpSXJEZ243LTVKQUIxV3ZXV05POXlGZXBETnVwRmc4SXpjNDZiM3lNV3ctVW5WUWNLYTJPbVQ0Zw?oc=5","date":"2023-11-08","type":"trial","source":"respiratory-therapy.com","summary":"Clinical Trial of RSV Vaccine Underway - respiratory-therapy.com","headline":"Clinical Trial of RSV Vaccine Underway - respiratory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNRTdlY282bFBZUXhZenl4TWJvOUhQekNWME5pWndGRTd3Ri1VLWV3ZU5IcERjZ0V2VGtOSlNySWdzXzVobmwzM0FJN3FrYXZEZ1NSR0FpLXMxYkZrNXRMNTBXUWVWOFAtYkNUQ2p6T2lfQ3ItTDB3TktDXzIxTzUwV0VJR25tV1E5anJWSEwxY2pJR0ZkbDFYVDMwRTExUHFoRm40dVh5djdabzd0MDdzVWhfLTRLSWpoaGc?oc=5","date":"2023-10-21","type":"regulatory","source":"reuters.com","summary":"Sanofi seeing 'unprecedented' demand for RSV therapy - reuters.com","headline":"Sanofi seeing 'unprecedented' demand for RSV therapy","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}